A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Consumer Reports has no financial relationship with any advertisers on this site. Bladder leaks can be disruptive — and they’re very common. Up to 30 percent of older adults experience incontinence.

Bladder leaks can be disruptive—and they’re very common. Up to 30 percent of older adults experience incontinence. The problem is more prevalent in women, but the percentage of men with an overactive ...

After successful Phase 3 trials, Indevus Pharmaceuticals Inc. has received a $10 million milestone payment from its partner in the development of overactive-bladder drugs Sanctura and Sactura XR, ...

Do you often feel a sudden, intense urge to urinate that disrupts your daily life? If so, you may be experiencing one of the most common overactive bladder symptoms. Understanding the signs to look ...

TOKYO, June 18 (Reuters) - Japan's Astellas Pharma <4503.T> said on Friday it was seeking approval from Japanese health authorities for a bladder control drug. Sign up here. The company said it was ...